Potential conflict of interest: Nothing to report.
Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study
Version of Record online: 30 JUL 2014
© 2014 by the American Association for the Study of Liver Diseases. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA
Volume 60, Issue 6, pages 1963–1971, December 2014
How to Cite
Murphy, G., Michel, A., Taylor, P. R., Albanes, D., Weinstein, S. J., Virtamo, J., Parisi, D., Snyder, K., Butt, J., McGlynn, K. A., Koshiol, J., Pawlita, M., Lai, G. Y., Abnet, C. C., Dawsey, S. M. and Freedman, N. D. (2014), Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study. Hepatology, 60: 1963–1971. doi: 10.1002/hep.27193
Supported by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study was supported by funding provided by the Intramural Research Program of the National Cancer Institute and US Public Health Service contracts (N01-CN-45165, N01-RC-45035, and N01-RC-37004).
- Issue online: 24 NOV 2014
- Version of Record online: 30 JUL 2014
- Accepted manuscript online: 2 MAY 2014 10:31PM EST
- Manuscript Accepted: 29 APR 2014
- Manuscript Received: 14 AUG 2013
Additional Supporting Information may be found at onlinelibrary.wiley.com/doi/10.1002/hep.27193/suppinfo.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.